Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review
Neuropsychiatric Disease and Treatment · 2023-03 · Volume 19 · 647-660
DOI: 10.2147/ndt.s401231 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neuropsychiatric Disease and Treatment, 2023-03. Verfasst von Jakub Hort und 2 weiteren Autor:innen. Beteiligte Einrichtung: Memory Clinic, Department of Neurology, Charles University, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Memory Clinic, Department of Neurology, Charles University, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic.
- Department of Neurology, Klinikum Bremen-Ost, Bremen, Germany.
- Research and Development, Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany.
ORCID-Profile: Jakub Hort, Robert Hoerr
Zitieren
APA
Hort, J., Duning, T., & Hoerr, R. (2023). Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review. Neuropsychiatric Disease and Treatment, Volume 19, 647-660. https://doi.org/10.2147/ndt.s401231
Vancouver
Hort J, Duning T, Hoerr R. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review. Neuropsychiatric Disease and Treatment. 2023;Volume 19:647-660. doi:10.2147/ndt.s401231
BibTeX
@article{Hort2023,
author = {Hort, Jakub and Duning, Thomas and Hoerr, Robert},
title = {Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review},
journal = {Neuropsychiatric Disease and Treatment},
year = {2023},
volume = {Volume 19},
pages = {647--660},
doi = {10.2147/ndt.s401231}
}
EUVIMED